---
figid: PMC4613999__kccy-13-21-973746-g001
figlink: /pmc/articles/PMC4613999/figure/f0001/
number: F1
caption: Loss of αV increases CTR1 expression affecting cDDP sensitivity and Cu-related
  signaling pathways. Loss of αV increases Sp1 that up-regulates CTR1 expression.
  Elevated CTR1 expression promotes the uptake of cDDP and enhances cDDP sensitivity.
  Cu provided by CTR1 is required for signaling from 4 important receptor tyrosine
  kinases (EGFR, PDGFR, FGFR and insulin receptor IR) that drive tumorigenesis, and
  for oncogene driven activity of the MAPK pathway.
pmcid: PMC4613999
papertitle: Integrin αV control of Cu homeostasis and cisplatin sensitivity.
reftext: Xinjian Lin, et al. Cell Cycle. 2014 Nov 1;13(21):3317-3318.
pmc_ranked_result_index: '74712'
pathway_score: 0.9658651
filename: kccy-13-21-973746-g001.jpg
figtitle: Loss of AV increases CTR1 expression affecting cDDP sensitivity and Cu-related
  signaling pathways
year: '2014'
organisms:
- Homo sapiens
ndex: 4211e5bd-deb4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4613999__kccy-13-21-973746-g001.html
  '@type': Dataset
  description: Loss of αV increases CTR1 expression affecting cDDP sensitivity and
    Cu-related signaling pathways. Loss of αV increases Sp1 that up-regulates CTR1
    expression. Elevated CTR1 expression promotes the uptake of cDDP and enhances
    cDDP sensitivity. Cu provided by CTR1 is required for signaling from 4 important
    receptor tyrosine kinases (EGFR, PDGFR, FGFR and insulin receptor IR) that drive
    tumorigenesis, and for oncogene driven activity of the MAPK pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGFR3
  - FGFR2
  - FGFRL1
  - PDGFRA
  - EGFR
  - MAPK3
  - FGFR1
  - PDGFRB
  - SGPL1
  - FGFR4
  - MAPK1
genes:
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: Spl
  symbol: SPL
  source: hgnc_alias_symbol
  hgnc_symbol: SGPL1
  entrez: '8879'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals: []
diseases: []
figid_alias: PMC4613999__F1
redirect_from: /figures/PMC4613999__F1
figtype: Figure
---
